| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -1.68M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NGEN returned -24.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -65.5% |
| 1 year | -24.0% |
| 5 years | +17.0% |
| All-time high | $5.60 (Dec 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NGEN would be worth today ›No. NervGen Pharma Corp. has not paid a dividend in the past 12 months.
NervGen Pharma Corp. stock trades on NASDAQ under the ticker symbol NGEN.
NervGen Pharma Corp. is part of the Healthcare sector.
NervGen Pharma Corp. has a market cap of 207.52M USD, based on the latest quote.
